Eloralintide High purity99% peptide ship worldwide
90 Inquiries
2883634-40-8
99%
shenzhen
WEIYA
5mg/10mg*10vials/box
Yes
2026-12-12
Tirzepatide,Retatrutide,Semaglutide,Melanotan,peptide,Selank
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionProduct Description
Elor5/Elor10Mechanism & benefits: Glucose-dependent insulin secretion, suppresses glucagon to lower blood glucose; delays gastric emptying, reduces appetite and caloric intake, supporting weight management and improving insulin sensitivity.Specification
Multiple strengths availableMultiple strengths are available: 10mg/5mgEach vial contains 10g, 10 vials per box.Minimum order: 1 box.Packing & Delivery
Secure Packaging, Prompt DeliveryWe offer multiple shipping options, with both China domestic warehouse and 3 warehouses in the US, plus warehouses in Australia, Europe and Canada.
· Specialized line shipping from China: ①.around 2 weeks②.FedEx: 5–7 days delivery.· Shipment from local warehouse: ①approx. 5 days②.Next-day delivery: receive the product the very next day.
Our packaging is secure and well-sealed. We guarantee a prompt reply within 24 hours, shipment within 48 hours after order placement, full logistics tracking and one-on-one dedicated service, to ensure the products reach you safely and intact.
Certifications
Purity over 99%, supports third-party verification
After Sales Service
Pre-sales: Multiple preferential policies are available for bulk orders, with customized discounts offered.In-sales: We provide real-time updates on shipment status. If parcels encounter customs detention or compliance issues, reshipment or refund options are available to ease your worries.After-sales: We offer continuous technical guidance for product application together with long-term after-sales protection, so you can sell with confidence.Company Profile
Weifang Weiya Trading Co., Ltd.established in 2014 ,is a globally recognized benchmark provider of one-stop CRO/CDMO services specialized in peptides.With 12 years of dedicated expertise in peptide manufacturing, we stand at the forefront of the industry and rank among China’s premier peptide manufacturers. We focus on peptide R&D, production and custom research services. Our products cover cosmetics, pharmaceuticals and scientific research fields, supplying peptide materials ranging from milligram to kilogram scales for global clients.We operate a GMP factory equipped with cutting-edge precision instruments for production, purification, testing, lyophilization and efficacy evaluation, including HPLC, LC-MS, GC, elemental analyzers and large-scale semi-preparative DAC-HPLC systems. We deliver high-quality peptides along with professional test reports such as purity analysis and mass spectrometry identification.Supported by an experienced R&D and production team, alongside a responsive sales team, we provide premium-quality products and thoughtful, dedicated service to every client.We have 3 warehouses in the US, plus warehouses in Australia, Europe and Canada.
ECHEMI Editorial ReferenceEloralintide (CAS No. 2883634-40-8) is a long-acting amylin analog and peptide-based pharmaceutical ingredient. Its modified peptide structure features a methylene thioacetal bridge and a C20 fatty diacid side chain, contributing to its distinctive molecular and physicochemical properties. As a peptide pharmaceutical raw material, Eloralintide is suitable for API research, analytical studies, and pharmaceutical development.
Basic Info-
Product Name:
Eloralintide
Other Name:Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136
CAS No.:2883634-40-8
Molecular Formula:C201H319N49O65S2
InChIKeys:RLBIFQNAUXZCQB-UHFFFAOYSA-N
Molecular Weight:4526
EC Number:262-076-3
Color/Form:White to off-white
Categories:
Characteristics-
XLogP3:
-12.2
Research-
Class:
Amylin receptor (AMYR) agonist (peptide, long-acting)
Status:Investigational — Phase 1/2 (T2DM and obesity)
Mechanism:Eloralintide is an amylin receptor agonist developed by Eli Lilly for type 2 diabetes and obesity. It activates the amylin receptor (AMYR), reducing food intake, delaying gastric emptying, and promoting satiety. It is structurally distinct from cagrilintide (Novo Nordisk). Being explored as monotherapy and in combination with GLP-1R agonists.
Activity note:Limited public data. Eloralintide is in early clinical development; specific EC50 values have not been publicly disclosed.
Source:MCE: Eloralintide (CAS 2883634-40-8); AbMole product data sheet.
References-
PubChem:Disclaimer:
Eloralintide is NOT FDA-approved or EMA-approved. It is in Phase 1/2 clinical development by Eli Lilly. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,Melanotan,peptide,Selank
-
Location:
Room 701, Unit 3, Building 7, Fanrong Zunfu, No.22 Mizhou East Road, Mizhou Subdistrict, Zhucheng City, Weifang City, Shandong Province, P.R.China
-
Payment Terms:
100% TT in advance
-
Average lead Time:
2 days
-
Total Annual Revenue:
$50 million-$100 million
-
Total Employees:
501-1000
-
Year of Establishment:
2026
Company Certificates-
RT10
-
MOTS
-
RT20
-
TR10
-
CAG
-
TR60
-
TR30
-
KPV GHK
-
-
Inquiry History90 Inquiries
Country Product Purchase Quantity Date Posted
United States
Eloralintide
30 MG Nov 15, 2026
United States
Eloralintide
10 PCS Nov 13, 2026
Norway
Eloralintide
1 MT Nov 13, 2026
Philippines
eloralintide
1 G Nov 12, 2026
United States
Eloralintide
20 MG Nov 9, 2026
United States
Eloralintide
1 MT Nov 8, 2026
United States
Eloralintide
100 G Oct 29, 2026
United States
Eloralintide
10 MG Oct 28, 2026
Philippines
Elora
5 MG Oct 27, 2026
Germany
Eloralintide, Lyophilised (Freeze-Dried) Peptides – High Purity / Low Endotoxin (LPS Removed)
100 Oct 26, 2026
United States
Eloralintide (LY-3841136)
1 Oct 24, 2026
Netherlands
Eloralintide
10 MG Oct 22, 2026
France
eloralintide
1 MT Oct 21, 2026
South Korea
Eloralintide
1 G Oct 21, 2026
United States
Eloralintide
10 PCS Oct 21, 2026
United Kingdom
Eloralintide
100 PCS Oct 20, 2026
United States
Eloralintide
20 MG Oct 19, 2026
United States
Eloralintide
1 MT Oct 16, 2026
United States
Eloralintide
10 MT Oct 10, 2026
Germany
Eloralintide
1 PCS Oct 10, 2026 Post an enquiry for this product
More from this Seller
-
-
-
KLOW peptide High purity 99% factory direct ship 80mg
/ 99%
$63/G FOB
-
-
-
-
BP5mg+TB5mg /BP 10mg+TB10mg High purity factory direct ship peptide
/ 99%
$61-63/G FOB
-
-
-
-
High purity peptide AHK-Cu factory direct ship
/ 99%
$60-61/G FOB
-
-
-
-
KS5/KS10 Kisspetin-10 High purity factory direct ship peptide
/ 99%
$60-62/G FOB
-







